Experience

Brainstorm Cell Therapeutics

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Vice President of Global Patient Advocacy and Government Affairs

  • Aug 2017 - Present

  Head of Brainstorm’s external engagement strategy with multiple professional, patient advocacy and government organizations. Engage directly with patient groups to understand patient needs and align efforts with ALS and MS patient communities. Support BrainStorm's commitment to building strong relationships and effective partnerships with rare disease patient advocacy and regenerative medicine organizations. Support clinical trial awareness and patient identification initiatives to support rapid trial enrollment and executionLead Brainstorm’s health policy and legislative strategic plans and manage government relationships. Engage at the Federal level by developing and cultivating relationships with diverse stakeholders. Set up and establish a government affairs strategy and program that promotes and executes legislative and regulatory strategies to protect or enhance BrainStorm's business interests. Monitor and track proposed federal legislation, lead analysis of proposed legislative/policy actions, determine the potential impact on the company and offer appropriate responses.Enhance and establish relationships with national and international trade associations including Biotechnology Innovation Organization- BIO and Alliance for Regenerative Medicine- ARM. Create specific opportunities for BrainStorm's business and operations in the legislative, policy, and political environments



Mitsubishi Tanabe Pharma America

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Senior Director, Government Affairs, Advocacy and Communications

  • 2016 - 2016

  Head of Government Affairs, Advocacy, and Communications to establish MT Pharma America in the United States. Lead advocacy efforts for commercialization of Product for ALS (Amyotrophic Lateral Sclerosis) New drug application accepted on August 30, 2016. First NDA accepted in 20 years for ALS (Amyotrophic Lateral Sclerosis). Work with ALS advocacy, medical and patient communities.Established Advocacy and Government Affairs functions and infrastructure. Head of Government Affairs, Advocacy, and Communications to establish MT Pharma America in the United States. Lead advocacy efforts for commercialization of Product for ALS (Amyotrophic Lateral Sclerosis) New drug application accepted on August 30, 2016. First NDA accepted in 20 years for ALS (Amyotrophic Lateral Sclerosis). Work with ALS advocacy, medical and patient communities.Established Advocacy and Government Affairs functions and infrastructure.



Bristol Myers Squibb

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of State Government Affairs and Advocacy

  • 2011 - 2016

  Led field-based team that is focused on appropriate access to pharmaceuticals and biologics, and legislative and policy actions that directly or indirectly impact broad business interests of BMS. Direct the development and maintenance of relationships with, and represent BMS to key state officials, policy makers, and leading advocacy groups. Establish relationships with patient/provider stakeholders on key health policy issues by educating, informing and activating them to protect patient access. Build Patient Advocacy infrastructure and function; manage and support advocacy team.

• Head of USP Advocacy

  • 2010 - 2011

  Direct Advocacy Center of Excellence and Advocacy Strategy for BMS USP. Contribute to the company’s evolving philosophy and long-term vision for patient advocacy, enhance the patient-centric culture within the company, and oversee the development of proactive approaches to managing BMS relationship with patient communities. Ensuring team has appropriate internal support, has identified, removed potential hurdles to meeting objectives. Accountable for tracking and analyzing trends in State and Federal policy as they relate to access and reimbursement for medications and developing strategic partnerships with third party allies to mitigate risk across 4 of 5 business units. Directed team State and regionally based Healthcare Alliance Liaison Professionals. Work with brand and business unit leads to implement alliance development as a core strategic capability.

• Associate Director, Healthcare Advocacy Liaison

  • 2007 - 2010

  Lead West Area Healthcare Alliance Liaison team while maintaining responsibility for advocacy relationships and access strategy in States of CO and AZ. Developed formalized training program for HAL Team. Collaborated across functional areas to maximize training curriculum. Developed HAL Policy Training Curriculum

• Associate Director, Mental Health Advocacy Liaison

  • 2005 - 2007

  Build strategic alliances with Mental Health advocates across assigned states to support open access to mental health medications. Work with Government Operations and Government Affairs to deliver consistent message to Medicaid, policy makers and legislators.Monitor legislative and regulatory developments pertaining to mental health policy at State and Federal level such as Medicaid PDLs, Deficit Reduction Act, Medicare Modernization Act and trends in evidence-based medicine.

• Region Business Director, Neuroscience Specialty

  • 2001 - 2005

  Built a NS specialty sales team to launch Abilify in the private office and institution settings in complex market of California. Developed pre and post launch business plan for the State of California to ensure sustainable sales growth. Plan Included patient flow and influence mapping of County mental health systems. Government affairs and operations point for NSS Team.